Find your next paid study

Pulnovo Medical, Inc.NCT07214376

~$10 – $8,750

Phase 3

EASi-HF Preserved - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) ≥40%

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricula…

Boehringer IngelheimNCT06424288

Phase 3

A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared With Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients wit…

Heart Failure and Impaired Kidney Function

AstraZenecaNCT06307652

Phase 2

Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

This study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Particip…

Novo Nordisk A/SNCT06979362

Phase 1

A Multi-center, Randomized, Participant- and Investigator- Blinded, Placebo-controlled Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of HJB647 in Participants With Chronic Stable Heart Failure With Reduced Ejection Fraction

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable he…

Heart Failure With Reduced Ejection Fraction

Novartis PharmaceuticalsNCT07465653

~$10 – $8,750

CHF - Congestive Heart Failure

Adherence Through Digital Health: Evaluating Randomized Engagement in Heart Failure

The goal of the ADHERE-HF study is to evaluate whether care-embedded, operationally delivered digital outreach improves medication refill, adherence, and clini…

Kaiser PermanenteNCT07831538

Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)

The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards APTURE transcatheter shunt system.

Edwards LifesciencesNCT03523416

Clinical Evidence With Biomarker Confirmation for PPMI in PCI Clinical Trials Study

The goal of this prospective, multicenter, non-randomized observational study is to better identify and understand periprocedural myocardial injury among adult…

Peri-procedural Myocardial InfarctionHeart Failure HospitalizationMortality+2 more

Baim Institute for Clinical ResearchNCT07848529

~$10 – $750

Heart Failure With Preserved Ejection Fraction (HFpEF)

Randomized Trial of ELEVATEd Cardiac Pacing Rate for Personalized Treatment of Heart Failure With Preserved Ejection Fraction (ELEVATE-HFpEF)

ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy o…

Medtronic Cardiac Rhythm and Heart FailureNCT06678841

Iron Deficiency (ID)Heart FailureHeart Failure and Reduced Ejection Fraction+1 more

Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure

The INITIATE-HF study is a cluster randomized controlled trial that aims to find out if reminding doctors about treatment guidelines for iron deficiency in adu…

Kaiser PermanenteNCT07467668

Phase 3

EASi-HF Reduced - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Chronic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) < 40%

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the…

Boehringer IngelheimNCT06935370

Chronic Obstructive Pulmonary DiseaseChronic Heart Failure

Mindful Steps: Coupling Technology and Mind-Body Exercise to Facilitate Physical Activity in Chronic Cardiopulmonary Disease

The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard…